Q4 2024 Earnings Call Transcript March 12, 2025 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.3, ...

OptimizeRx Corp (OPRX) reports a 14% increase in fourth-quarter revenue and significant gross margin improvement, while transitioning to a subscription-based model for enhanced predictability.

OptimizeRx (OPRX) delivered earnings and revenue surprises of 20% and 9.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Q4 2024 Results Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsSteve Silvestro - PresidentEdward ...

OptimizeRx reports sales of $32.32M in Q4, beating consensus, with adjusted EPS of $0.30. Full-year revenue increased 29% and ...

Lake Street analyst Eric Martinuzzi maintained a Buy rating on OptimizeRx (OPRX – Research Report) today and set a price target of $11.00. The ...

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.

OPTIMIZERX ($OPRX) posted quarterly earnings results on Wednesday, March 12th. The company reported earnings of $0.30 per share, beating estimates of $0.28 by $0.02 ...

While OptimizeRx Corporation ( NASDAQ:OPRX ) might not have the largest market cap around , it saw a double-digit ...

OptimizeRx (NASDAQ:OPRX – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect OptimizeRx to post earnings of $0.25 ...

Reports Q4 revenue $32.317M, consensus $30.36M. Stephen Silvestro, OptimizeRx (OPRX) CEO commented, “I’m incredibly proud of our strong fourth ...